title: CYP2D6 pharmacogenomics of tamoxifen treatment.
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics; D019389:Cytochrome P-450 CYP2D6 / Q000008:administration & dosage* / Q000235:genetics / Q000627:therapeutic use; D017277:Drug Approval; D005260:Female; D005838:Genotype; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000201:enzymology*; D010597:Pharmacogenetics / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D013629:Tamoxifen / Q000008:administration & dosage / Q000627:therapeutic use*; D013673:Technology Assessment, Biomedical; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen; D019389:Cytochrome P-450 CYP2D6